MX2008002456A - Uso de ambroxol para el tratamiento de infecciones por rinovirus. - Google Patents
Uso de ambroxol para el tratamiento de infecciones por rinovirus.Info
- Publication number
- MX2008002456A MX2008002456A MX2008002456A MX2008002456A MX2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A
- Authority
- MX
- Mexico
- Prior art keywords
- ambroxol
- treatment
- rhinovirus
- rhinovirus infections
- medical composition
- Prior art date
Links
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 title abstract 4
- 229960005174 ambroxol Drugs 0.000 title abstract 4
- 206010061494 Rhinovirus infection Diseases 0.000 title abstract 2
- 241000430519 Human rhinovirus sp. Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107792 | 2005-08-25 | ||
| PCT/EP2006/064999 WO2007023072A2 (en) | 2005-08-25 | 2006-08-03 | Use of ambroxol for the treatment of rhinovirus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008002456A true MX2008002456A (es) | 2008-04-07 |
Family
ID=35519889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008002456A MX2008002456A (es) | 2005-08-25 | 2006-08-03 | Uso de ambroxol para el tratamiento de infecciones por rinovirus. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20080319087A1 (enExample) |
| EP (1) | EP1928444A2 (enExample) |
| JP (1) | JP2009506002A (enExample) |
| BR (1) | BRPI0614887A2 (enExample) |
| CA (1) | CA2619863A1 (enExample) |
| MX (1) | MX2008002456A (enExample) |
| RU (1) | RU2409356C2 (enExample) |
| WO (1) | WO2007023072A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012123466A1 (de) * | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim International Gmbh | Verwendung einer sprühfähigen zusammensetzung enthaltend ambroxol |
| KR101915056B1 (ko) | 2012-04-10 | 2018-11-07 | 한미약품 주식회사 | 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법 |
| CN104606170A (zh) * | 2015-02-04 | 2015-05-13 | 上海华源安徽仁济制药有限公司 | 一种盐酸氨溴索胶囊及其制备方法 |
| CN105078896A (zh) * | 2015-09-22 | 2015-11-25 | 青岛华之草医药科技有限公司 | 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂 |
| RU2701737C1 (ru) * | 2018-06-28 | 2019-10-01 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Лекарственное средство для терапии хронических ран |
| IT201800006909A1 (it) * | 2018-07-04 | 2020-01-04 | Polvere secca di ambroxolo per uso inalatorio con target bronchiale | |
| US11013687B1 (en) * | 2020-06-08 | 2021-05-25 | Amcyte Pharma, Inc. | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 |
| WO2021255129A1 (en) * | 2020-06-16 | 2021-12-23 | Spedding Research Solutions, Sas | Novel use of a modulator of glucosylceramide degradation for viral infections |
| EP4196154A4 (en) | 2020-08-13 | 2025-01-22 | Texas Southern University | COMPOSITIONS AND METHODS FOR INHIBITING SARS-COV-2 INFECTION |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3610997A1 (de) * | 1986-04-02 | 1987-10-15 | Krewel Werke Gmbh | Ambroxol-nasenspray |
| KR20040045429A (ko) * | 2001-09-04 | 2004-06-01 | 베링거 인겔하임 인터내셔날 게엠베하 | 항인플루엔자 약제 |
| US20050075403A1 (en) * | 2003-10-02 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of inflammation in the pharynx |
-
2006
- 2006-08-03 WO PCT/EP2006/064999 patent/WO2007023072A2/en not_active Ceased
- 2006-08-03 EP EP06792668A patent/EP1928444A2/en active Pending
- 2006-08-03 JP JP2008527426A patent/JP2009506002A/ja active Pending
- 2006-08-03 RU RU2008110933/15A patent/RU2409356C2/ru active
- 2006-08-03 BR BRPI0614887-5A patent/BRPI0614887A2/pt not_active IP Right Cessation
- 2006-08-03 CA CA002619863A patent/CA2619863A1/en not_active Abandoned
- 2006-08-03 US US12/063,874 patent/US20080319087A1/en not_active Abandoned
- 2006-08-03 MX MX2008002456A patent/MX2008002456A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007023072A2 (en) | 2007-03-01 |
| WO2007023072A3 (en) | 2007-05-03 |
| BRPI0614887A2 (pt) | 2011-04-19 |
| US20080319087A1 (en) | 2008-12-25 |
| RU2008110933A (ru) | 2009-09-27 |
| JP2009506002A (ja) | 2009-02-12 |
| RU2409356C2 (ru) | 2011-01-20 |
| EP1928444A2 (en) | 2008-06-11 |
| CA2619863A1 (en) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY155255A (en) | Spiro-oxindole compounds and their use as therapeutic agents | |
| DK1970059T3 (da) | Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser | |
| SG170101A1 (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
| WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
| SG150531A1 (en) | Use of meloxicam for the treatment of respiratory diseases in pigs | |
| MX2009004561A (es) | Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor. | |
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| ZA200703002B (en) | Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity | |
| EA200802412A1 (ru) | Терапевтические комбинации для сопровождающихся болью медицинских состояний | |
| ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| UA92000C2 (en) | 1-benzylindole-2-carboxamide derivatives | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| TW200616608A (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| EA201300421A1 (ru) | Комбинированная терапия для лечения инфекции hcv | |
| ZA202006072B (en) | Ret inhibitor for use in treating cancer having a ret alteration | |
| WO2006047716A3 (en) | Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease | |
| ATE543492T1 (de) | Behandlung von lungenkrebs | |
| UA85471C2 (ru) | Применение оксикодона для лечения висцеральной боли | |
| MX2008002456A (es) | Uso de ambroxol para el tratamiento de infecciones por rinovirus. | |
| DK1670489T3 (da) | Brug af xenon med hypotermi til behandling af neonatal asfyksi | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| PL1732551T3 (pl) | Perheksylina do leczenia przewlekłej niewydolności serca | |
| WO2008088987B1 (en) | Treatment of pain with naloxone | |
| BR112022000734A2 (pt) | Método para tratar câncer em um paciente, uso de composto 1, e, composto 1 | |
| EA200901145A1 (ru) | Применение рибофлавина в лечении гипертензии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |